A theory for the mechanism of homocysteine-induced vascular pathogenesis

Medical Hypotheses

Volumn 53, Issue 5, 1999, Pages 386-394

  Wang, Xiao ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHELATING AGENT; CALCIUM ION; CHOLESTEROL; HOMOCYSTEINE; MEMBRANE PHOSPHOLIPID;

BLOOD CLOTTING; BLOOD VESSEL INJURY; CELL ADHESION; CELL JUNCTION; CELL MOTION; CELL SHAPE; CHELATION; CYTOSKELETON; ENDOTHELIUM LESION; FOAM CELL; HUMAN; HYPOTHESIS; INFLAMMATION; MEMBRANE FLUIDITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; THROMBOSIS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0032745196     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1998.0787     Document Type: Article

References (81)

1. McCully K. S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 56:1969;111-128.
2. Duell P. B., Malinow M. R. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol. 8:1997;28-34.
3. Selhub J. Mild hyperhomocysteinemia and arterial occlusive disease. Haematologica. 82:1997;129-132.
4. Rosenberg I. H. Homocysteine, vitamins and arterial occlusive disease: an overview. J. Nutr. 126:1996;1235S-1237S.
5. Stampfer M. J., Rimm E. B. Folate and cardiovascular disease. Why we need a trial now. J Am Med Assoc. 275:1996;1929-1930.
6. Nygard O., Nordrehaug J. E., Repsum H., Ueland P. M., Farstad M., Vollset S. E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
7. Boushey C. J., Beresford S. A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable bene1/2ts of increasing folic acid intakes. J Am Med Assoc. 274:1995;1049-1057.
8. D'Angelo A., Mazzola G., Crippa L., Fermo I., Vigano D. A. S. Hyperhomocysteinemia and venous thromboembolic disease. Haematologica. 82:1997;211-219.
9. Kluger J. Beyond cholesterol. Time. August 4:1997;48.
10. Stacey M. The fall and rise of Kilmer McCully. New York Times Mag. 10:1997 August;25-29.
11. Pilgeram L. Perspective: a mechanism underlying homocysteinemia and increased risk of coronary artery and cerebrovascular disease. Circulation. 94:1996;2990.
12. Hultberg B., Andersson A., Isaksson A. Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937). Biochim Biophys Acta. 1269:1995;6-12.
13. Clarke R., Naughten E., Cahalane S. The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia. Ir J Med Sci. 161:1992;561-564.
14. Rodgers G. M., Conn M. T. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 75:1990;895-901.
15. Frauscher G., Karnaukhova E., Muehl A., Hoeger H., Lubec B. Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage. Life Sci. 57:1995;813-817.
16. Fryer R. H., Wilson B. D., Gubler D. B., Fitzgerald L. A., Rodgers G. M. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb. 13:1993;1327-1333.
17. Wilcken D. E., Dudman N. P. Mechanisms of thrombogenesis and accelerated atherogenesis in homocysteinaemia. Haemostasis. 1:1989;14-23.
18. McCully K. S. Chemical pathology of homocysteine. I. Atherogenesis. Ann Clin Lab Sci. 23:1993;477-493.
19. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem. 272:1997;1935-1942.
20. Mason J. B., Miller J. W. The effects of vitamins B12, B6, and folate on blood homocysteine levels. Ann NY Acad Sci. 669:1992;197-203.
21. Graham I. M., Daly L. E., Refsum H. M. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J Am Med Assoc. 277:1997;1775-1781.
22. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 57:1995;791-804.
23. Wang X. A chelate theory for the mechanism of action of aspirin-like drugs. Med Hypotheses. 50:1998;239-251.
24. Wang X. Aspirin-like drugs cause gastrointestinal injuries by metallic cation chelation. Med Hypotheses. 50:1998;227-238.
25. Craig D. P., Nyholm R. S. The nature of the metal-ligand bond. Dwyer F. P., Mellor D. P. Chelating Agents and Metal Chelates. 1964;51-93 Academic Press, New York.
26. Kauffman G. B. Chelate. The Encyclopedia Americana - International Edition. 1993;Grolier Incorporated, Danbury, CT. p. 362.
27. Harris C. M., Livingstone S. E. Bidentate chelates. Dwyer F. P., Mellor D. P. Chelating Agents and Metal Chelates. 1964;95-141 Academic Press, New York.
28. Greenstein J. P., Winitz M. Amino acids as dipolar ions. Chemistry of the Amino Acids. 1961;John Wiley & Sons, New York. p. 435-522.
29. Martell A. E., Calvin M. Chemistry of the Metal Chelate Compounds. 1952;Prentice-Hall, Englewood Cliffs, NJ.
30. Ha J. Coordination compounds. McHenry R. The New Encyclopaedia Britannica. 1993;884-892 Encyclopaedia Britannica, Chicago, IL.
31. Dyatlova N. M., Temkina Y. V., Popov K. I. Present-day aspects of complexon coordination chemistry. Buslaev Y. Complex Formation and Stereochemistry of Coordination Compounds. 1996;1-48 Nova Science Publishers, New York.
32. Greenstein J. P., Winitz M. Metal and salt combinations with amino acids. Chemistry of the Amino Acids. 1961;John Wiley and Sons, New York. p. 569-682.
33. Davies C. W., Waind G. M. The extent of dissociation of salts in water. Part XII. Calcium salts of some amino-acids and dipeptides. J Chem Soc. 1950:1950;301-303.
34. Takeda A., Okada S. Chemical form of tumor-tropic 99mTc-DL- homocysteine. Int J Radiat Appl Instrum Part A-Appl Radiat Isot. 40:1989;565-568.
35. McHenry R. The New Encyclopaedia Britannica. 1993;151-152 Encyclopaedia Britannica, Chicago, IL.
36. Dejana E., Zanetti A., Del Maschio A. Adhesive proteins at endothelial cell-to-cell junctions and leukocyte extravasation. Haemostasis. 4:1996;210-219.
37. Contreras R. G., Miller J. H., Zamora M., Gonzalez-Mariscal L., Cereijido M. Interaction of calcium with plasma membrane of epithelial (MDCK) cells during junction formation. Am J Physiol. 263:1992;C313-C318.
38. Martinez-Palomo A., Meza I., Beaty G., Cereijido M. Experimental modulation of occluding junctions in a cultured transporting epithelium. J Cell Biol. 87:1980;736-745.
39. Kniesel U., Risau W., Wolburg H. Development of blood-brain barrier tight junctions in the rat cortex. Brain Res Dev Brain Res. 96:1996;229-240.
40. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 9:1993;317-321.
41. Breviario F., Caveda L., Corada M. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol. 15:1995;1229-1239.
42. Breier G., Breviario F., Caveda L. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood. 87:1996;630-641.
43. Ayalon O., Sabanai H., Lampugnani M. G., Dejana E., Geiger B. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol. 126:1994;247-258.
44. Albelda S. M., Muller W. A., Buck C. A., Newman P. J. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol. 114:1991;1059-1068.
45. Smith J. W., Piotrowicz R. S., Mathis D. A mechanism for divalent cation regulation of beta 3-integrins. J Biol Chem. 269:1994;960-967.
46. Jaffe E. A. Endothelial cell structure and function. Hoffman R., Benz E. J. Jr, Shattil S. J., Furie B., Cohen H. J. Hematology. Basic Principles and Practice. 1991;1198-1213 Churchill Livingstone, New York.
47. Norgard-Sumnicht K., Varki A. Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups. J Biol Chem. 270:1995;12012-12024.
48. Cliff, W. J. Blood Vessels, Cambridge University Press, London, 1976.
49. Mansoor M. A., Ueland P. M., Aarsland A., Svardal A. M. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism. 42:1993;1481-1485.
50. Malinow M. R. Homocyst(e)ine and arterial occlusive diseases. J Intern Med. 236:1994;603-617.
51. Kang S. S., Wong P. W., Curley K. The effect of D-penicillamine on protein-bound homocyst(e)ine in homocystinurics. Pediatr Res. 16:1982;370-372.
52. Harker L. A., Ross R., Slichter S. J., Scott C. R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 58:1976;731-741.
53. Dudman N. P., Hicks C., Wang J., Wilcken D. E. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis. 91:1991;77-83.
54. Siggaard-Andersen O., Thode J., Fogh-Andersen N. What is 'ionized calcium'. Scand J Clin Lab Invest. 43:1983;11-16.
55. Li T. K., Piechocki J. T. Determination of serum ionic calcium with an ion-selective electrode: evaluation of methodology and normal values. Clin Chem. 17:1971;411-416.
56. Umemoto M., Tani W., Kuwa K., Ujihira Y. Measuring calcium in plasma. Anal Chem. 66:1994;351A-356A.
57. Tong I. K., Yau P., Overduin M. et al. Purification and spectroscopic characterization of a recombinant amino-terminal polypeptide fragment of mouse epithelial cadherin. FEBS Lett. 352:1994;318-322.
58. Albert A. Quantitative studies of the avidity of naturally occurring substances for trace metals. 2. Amino-acids having three ionizing groups. Biochem J. 50:1952;690-698.
59. Monk C. B. Electrolytes in solutions of amino acids. Part IV. Dissociation constants of metal complexes of glycine, alanine and glycyl-glycine from pH titrations. Trans Faraday Soc. 47:1951;297-302.
60. Li N., Manning R. A. Some metal complexes of sulfur-containing amino acids. J Am Chem Soc. 77:1955;5225-5228.
61. van der Merwe P. A., Barclay A. N. Transient intercellular adhesion: the importance of weak protein-protein interactions. Trends Biochem Sci. 19:1994;354-358.
62. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
63. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med. 314:1986;488-500.
64. Jackson R. L., Gotto A. M. J. Hypothesis concerning membrane structure, cholesterol, and atherosclerosis. Atherosclerosis Rev. 1:1976;1-21.
65. Singer S. J., Nicolson G. L. The fluid mosaic model of the structure of cell membranes. Science. 175:1972;720-731.
66. Lynch R. D., Tkachuk L. J., Ji X., Rabito C. A., Schneeberger E. E. Depleting cell cholesterol alters calcium-induced assembly of tight junctions by monolayers of MDCK cells. Eur J Cell Biol. 60:1993;21-30.
67. Phillips M. C., Johnson W. J., Rothblat G. H. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim Biophys Acta. 906:1987;223-276.
68. Cain H., Krauspe R., Kraus B. The cystoskeleton in activated and in functionally disordered cells of the macrophage system. Pathol Res Pract. 175:1982;162-179.
69. McGookey D. J., Anderson R. G. Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells. J Cell Biol. 97:1983;1156-1168.
70. Franke W. W., Hergt M., Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell. 49:1987;131-141.
71. Lieber J. G., Evans R. M. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J Cell Sci. 109:1996;3047-3058.
72. Traub P., Perides G., Schimmel H., Scherbarth A. Interaction in vitro of nonepithelial intermediate filament proteins with total cellular lipids, individual phospholipids, and a phospholipid mixture. J Biol Chem. 261:1986;10558-10568.
73. Traub P., Perides G., Kuehn S., Scherbarth A. Efficient interaction of nonpolar lipids with intermediate 1/2laments of the vimentin type. Fur J Cell Biol. 43:1987;55-64.
74. Ono M., Murakami T., Tomita M., Ishikawa H. Association of the actin cytoskeleton with glass-adherent proteins in mouse peritoneal macrophages. Biol Cell. 77:1993;219-230.
75. Trotter J. A. The organization of actin in spreading macrophages. The actin-cytoskeleton of peritoneal macrophages is linked to the substratum via transmembrane connections. Exp Cell Res. 132:1981;235-248.
76. Rinnerthaler G., Herzog M., Klappacher M., Kunka H., Small J. V. Leaving edge movement and ultrastructure in mouse macrophages. J Struct Biol. 106:1991;1-16.
77. Harpel P. C., Zhang X., Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr. 126:1996;1285S-1289S.
78. Gertler J. P., Abbott W. M. Prothrombotic and fibrinolytic function of normal and perturbed endothelium. J Surg Res. 52:1992;89-95.
79. Davis J. W., Flournoy L. D., Phillips P. E. Amino acids and collagen-induced platelet aggregation. Lack of effect of three amino acids that are elevated in homocystinuria. Am J Dis Child. 129:1975;1020-1021.
80. Smith L. H. J. Errors in membrane transport. Thorn G. W., Adams R. D., Braunwald E., Isselbacher K. J., Petersdorf R. G. Harrison's Principles of Internal Medicine, 8th edn. 1977;635-638 McGraw-Hill, New York.
81. Smith L. H. J. Genetic disorders of amino acid metabolism. Thorn G. W., Adams R. D., Braunwald E., Isselbacher K. J., Petersdorf R. G. Harrison's Principles of Internal Medicine, 8th edn. 1977;626-632 McGraw-Hill, New York.